Free Trial

Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Stevanato Group logo with Medical background

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company.

Several research firms have commented on STVN. UBS Group lowered their price objective on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday, March 7th. William Blair restated an "outperform" rating on shares of Stevanato Group in a research report on Monday. Finally, Stephens upgraded Stevanato Group to a "strong-buy" rating in a research note on Monday, April 21st.

Get Our Latest Stock Analysis on STVN

Stevanato Group Stock Performance

Shares of STVN stock traded up €0.11 ($0.13) on Tuesday, hitting €24.59 ($28.93). The company had a trading volume of 152,808 shares, compared to its average volume of 336,173. Stevanato Group has a twelve month low of €17.12 ($20.14) and a twelve month high of €25.88 ($30.45). The company has a quick ratio of 1.26, a current ratio of 1.83 and a debt-to-equity ratio of 0.22. The firm has a market cap of $7.45 billion, a P/E ratio of 48.22, a price-to-earnings-growth ratio of 2.37 and a beta of 0.55. The company has a 50-day moving average price of €23.20 and a 200-day moving average price of €21.94.

Stevanato Group Increases Dividend

The company also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Investors of record on Thursday, June 5th will be issued a $0.0613 dividend. This represents a yield of 0.3%. This is a boost from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date of this dividend is Thursday, June 5th.

Institutional Investors Weigh In On Stevanato Group

Several large investors have recently bought and sold shares of the company. Whittier Trust Co. acquired a new stake in shares of Stevanato Group in the first quarter worth approximately $27,000. Twin Tree Management LP acquired a new stake in Stevanato Group during the 1st quarter worth $29,000. Johnson Financial Group Inc. purchased a new stake in shares of Stevanato Group during the fourth quarter worth $41,000. SVB Wealth LLC acquired a new stake in shares of Stevanato Group in the first quarter valued at about $46,000. Finally, Van Berkom & Associates Inc. lifted its stake in shares of Stevanato Group by 33.3% in the first quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company's stock worth $49,000 after buying an additional 600 shares in the last quarter.

Stevanato Group Company Profile

(Get Free Report

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Stories

Analyst Recommendations for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines